{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:12:36Z","timestamp":1792494756931,"version":"4.5.0"},"reference-count":56,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1111070007"],"award-info":[{"award-number":["2022B1111070007"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00005-023-00685-w","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T04:01:15Z","timestamp":1693022475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Improved Production of Anti-FGF-2 Nanobody Using Pichia pastoris and Its Effect on Antiproliferation of Keratinocytes and Alleviation of Psoriasis"],"prefix":"10.2478","volume":"71","author":[{"given":"Zhenlong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baixin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"key":"685_CR1","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1007\/s00253-014-5732-5","volume":"98","author":"M Ahmad","year":"2014","unstructured":"Ahmad M, Hirz M, Pichler H et al (2014) Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol 98:5301\u20135317. https:\/\/doi.org\/10.1007\/s00253-014-5732-5","journal-title":"Appl Microbiol Biotechnol"},{"key":"685_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/1568010054022033","volume":"4","author":"C Albanesi","year":"2005","unstructured":"Albanesi C, Scarponi C, Giustizieri M et al (2005) Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 4:329\u2013334. https:\/\/doi.org\/10.2174\/1568010054022033","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"685_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40257-017-0328-3","volume":"19","author":"M Amin","year":"2018","unstructured":"Amin M, No DJ, Egeberg A et al (2018) Choosing first-line biologic treatment for moderate-to-severe psoriasis: What does the evidence say? Am J Clin Dermatol 19:1\u201313. https:\/\/doi.org\/10.1007\/s40257-017-0328-3","journal-title":"Am J Clin Dermatol"},{"key":"685_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00403-006-0723-8","volume":"298","author":"C Andrys","year":"2007","unstructured":"Andrys C, Borska L, Pohl D et al (2007) Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman\u2019s therapy. Arch Dermatol Res 298:479\u2013483. https:\/\/doi.org\/10.1007\/s00403-006-0723-8","journal-title":"Arch Dermatol Res"},{"key":"685_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323:1945. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"685_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/bab.1226","volume":"63","author":"R Baghban","year":"2016","unstructured":"Baghban R, Gargari SLM, Rajabibazl M et al (2016) Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris: Nanobody against Clostridium botulinum neurotoxin E. Biotechnol Appl Biochem 63:200\u2013205. https:\/\/doi.org\/10.1002\/bab.1226","journal-title":"Biotechnol Appl Biochem"},{"key":"685_CR7","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.2147\/CMAR.S186042","volume":"11","author":"F Battaglin","year":"2019","unstructured":"Battaglin F, Puccini A, Ahcene Djaballah S et al (2019) The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer. Cancer Manag Res 11:5911\u20135924. https:\/\/doi.org\/10.2147\/CMAR.S186042","journal-title":"Cancer Manag Res"},{"key":"685_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","volume":"100","author":"JD Beatty","year":"1987","unstructured":"Beatty JD, Beatty BG, Vlahos WG (1987) Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 100:173\u2013179. https:\/\/doi.org\/10.1016\/0022-1759(87)90187-6","journal-title":"J Immunol Methods"},{"key":"685_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1570161043476500","volume":"2","author":"C-H Chen","year":"2004","unstructured":"Chen C-H, Poucher S, Lu J et al (2004) Fibroblast growth factor 2: from laboratory evidence to clinical application. Curr Vasc Pharmacol 2:33\u201343. https:\/\/doi.org\/10.2174\/1570161043476500","journal-title":"Curr Vasc Pharmacol"},{"key":"685_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2859-5-17","volume":"5","author":"O Cos","year":"2006","unstructured":"Cos O, Ram\u00f3n R, Montesinos JL et al (2006) Operational strategies, monitoring and control of heterologous protein production in the methylotrophic yeast Pichia pastoris under different promoters: a review. Microb Cell Fact 5:17. https:\/\/doi.org\/10.1186\/1475-2859-5-17","journal-title":"Microb Cell Fact"},{"key":"685_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cytogfr.2005.01.007","volume":"16","author":"L Dailey","year":"2005","unstructured":"Dailey L, Ambrosetti D, Mansukhani A et al (2005) Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16:233\u2013247. https:\/\/doi.org\/10.1016\/j.cytogfr.2005.01.007","journal-title":"Cytokine Growth Factor Rev"},{"key":"685_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1046\/j.1523-1755.1999.00610.x","volume":"56","author":"N Ferrara","year":"1999","unstructured":"Ferrara N (1999) Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56:794\u2013814. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00610.x","journal-title":"Kidney Int"},{"key":"685_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","volume":"53","author":"J Gao","year":"2020","unstructured":"Gao J, Chen F, Fang H et al (2020) Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Biol Res 53:48. https:\/\/doi.org\/10.1186\/s40659-020-00316-0","journal-title":"Biol Res"},{"key":"685_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jid.2019.01.026","volume":"139","author":"N Garzorz-Stark","year":"2019","unstructured":"Garzorz-Stark N, Eyerich K (2019) Psoriasis pathogenesis: keratinocytes are back in the spotlight. J Invest Dermatol 139:995\u2013996. https:\/\/doi.org\/10.1016\/j.jid.2019.01.026","journal-title":"J Invest Dermatol"},{"key":"685_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.32508\/stdj.v23i2.1746","volume":"23","author":"LK Han","year":"2020","unstructured":"Han LK, Oanh NCK, Nghia NH et al (2020) Secretory expression of the recombinant FGF-2 protein in Pichia pastoris carrying multiple copies of target gene. VNUHCM J Sci Technol Dev 23:499\u2013507. https:\/\/doi.org\/10.32508\/stdj.v23i2.1746","journal-title":"VNUHCM J Sci Technol Dev"},{"key":"685_CR16","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/jid.2009.65","volume":"129","author":"EG Harper","year":"2009","unstructured":"Harper EG, Guo C, Rizzo H et al (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129:2175\u20132183. https:\/\/doi.org\/10.1038\/jid.2009.65","journal-title":"J Invest Dermatol"},{"key":"685_CR17","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.2147\/DDDT.S167149","volume":"12","author":"I Haugh","year":"2018","unstructured":"Haugh I, Preston A, Kivelevitch D et al (2018) Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis. Drug Des Devel Ther 12:3879\u20133883. https:\/\/doi.org\/10.2147\/DDDT.S167149","journal-title":"Drug Des Devel Ther"},{"key":"685_CR18","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1007\/s00253-012-4582-2","volume":"97","author":"H Hoshida","year":"2013","unstructured":"Hoshida H, Fujita T, Cha-aim K et al (2013) N-glycosylation deficiency enhanced heterologous production of a Bacillus licheniformis thermostable \u03b1-amylase in Saccharomyces cerevisiae. Appl Microbiol Biotechnol 97:5473\u20135482. https:\/\/doi.org\/10.1007\/s00253-012-4582-2","journal-title":"Appl Microbiol Biotechnol"},{"key":"685_CR19","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3389\/fimmu.2017.01442","volume":"8","author":"Y Hu","year":"2017","unstructured":"Hu Y, Liu C, Muyldermans S (2017) Nanobody-based delivery systems for diagnosis and targeted tumor therapy. Front Immunol 8:1442. https:\/\/doi.org\/10.3389\/fimmu.2017.01442","journal-title":"Front Immunol"},{"key":"685_CR20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","volume":"12","author":"M Jabeen","year":"2020","unstructured":"Jabeen M, Boisgard A-S, Danoy A et al (2020) Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics 12:789. https:\/\/doi.org\/10.3390\/pharmaceutics12090789","journal-title":"Pharmaceutics"},{"key":"685_CR21","doi-asserted-by":"publisher","first-page":"109615","DOI":"10.1016\/j.biopha.2019.109615","volume":"121","author":"B-W Jiang","year":"2020","unstructured":"Jiang B-W, Zhang W-J, Wang Y et al (2020) Convallatoxin induces HaCaT cell necroptosis and ameliorates skin lesions in psoriasis-like mouse models. Biomed Pharmacother 121:109615. https:\/\/doi.org\/10.1016\/j.biopha.2019.109615","journal-title":"Biomed Pharmacother"},{"key":"685_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","volume":"34","author":"I Jov\u010devska","year":"2020","unstructured":"Jov\u010devska I, Muyldermans S (2020) The therapeutic potential of nanobodies. BioDrugs 34:11\u201326. https:\/\/doi.org\/10.1007\/s40259-019-00392-z","journal-title":"BioDrugs"},{"key":"685_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2217\/nnm.14.178","volume":"10","author":"M Kijanka","year":"2015","unstructured":"Kijanka M, Dorresteijn B, Oliveira S et al (2015) Nanobody-based cancer therapy of solid tumors. Nanomedicine 10:161\u2013174. https:\/\/doi.org\/10.2217\/nnm.14.178","journal-title":"Nanomedicine"},{"key":"685_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2133.2004.06009.x","volume":"151","author":"T Kormeili","year":"2004","unstructured":"Kormeili T, Lowe NJ, Yamauchi PS (2004) Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences. Br J Dermatol 151:3\u201315. https:\/\/doi.org\/10.1111\/j.1365-2133.2004.06009.x","journal-title":"Br J Dermatol"},{"key":"685_CR25","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s12033-022-00464-6","volume":"64","author":"N Kov\u00e1cs","year":"2022","unstructured":"Kov\u00e1cs N, Farsang R, Szigeti M et al (2022) Enhanced recombinant protein production of soluble, highly active and immobilizable PNGase F. Mol Biotechnol 64:914\u2013918. https:\/\/doi.org\/10.1007\/s12033-022-00464-6","journal-title":"Mol Biotechnol"},{"key":"685_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejphar.2018.01.048","volume":"824","author":"Y-H Kuang","year":"2018","unstructured":"Kuang Y-H, Lu Y, Liu Y-K et al (2018) Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes. Eur J Pharmacol 824:57\u201363. https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.048","journal-title":"Eur J Pharmacol"},{"key":"685_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2217\/imt-2020-0292","volume":"13","author":"L Landeck","year":"2021","unstructured":"Landeck L, Sabat R, Ghoreschi K et al (2021) Immunotherapy in psoriasis. Immunotherapy 13:605\u2013619. https:\/\/doi.org\/10.2217\/imt-2020-0292","journal-title":"Immunotherapy"},{"key":"685_CR28","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.drudis.2022.05.002","volume":"27","author":"L Ledsgaard","year":"2022","unstructured":"Ledsgaard L, Ljungars A, Rimbault C et al (2022) Advances in antibody phage display technology. Drug Discov Today 27:2151\u20132169. https:\/\/doi.org\/10.1016\/j.drudis.2022.05.002","journal-title":"Drug Discov Today"},{"key":"685_CR29","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s41467-018-03704-z","volume":"9","author":"H Li","year":"2018","unstructured":"Li H, Yao Q, Mariscal AG et al (2018) Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation. Nat Commun 9:1420. https:\/\/doi.org\/10.1038\/s41467-018-03704-z","journal-title":"Nat Commun"},{"key":"685_CR30","doi-asserted-by":"publisher","first-page":"e1697","DOI":"10.1002\/wnan.1697","volume":"13","author":"M Liu","year":"2021","unstructured":"Liu M, Li L, Jin D et al (2021) Nanobody\u2014a versatile tool for cancer diagnosis and therapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 13:e1697. https:\/\/doi.org\/10.1002\/wnan.1697","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"685_CR31","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","volume":"139","author":"S Moos","year":"2019","unstructured":"Moos S, Mohebiany AN, Waisman A et al (2019) Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. J Invest Dermatol 139:1110\u20131117. https:\/\/doi.org\/10.1016\/j.jid.2019.01.006","journal-title":"J Invest Dermatol"},{"key":"685_CR32","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/annonc\/mdw214","volume":"27","author":"L Paz-Ares","year":"2016","unstructured":"Paz-Ares L, Socinski MA, Shahidi J et al (2016) Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine\u2013cisplatin plus necitumumab versus gemcitabine\u2013cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer. Ann Oncol 27:1573\u20131579. https:\/\/doi.org\/10.1093\/annonc\/mdw214","journal-title":"Ann Oncol"},{"key":"685_CR33","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1002\/jps.21765","volume":"98","author":"A Peng","year":"2009","unstructured":"Peng A, Gaitonde P, Kosloski MP et al (2009) Effect of route of administration of human recombinant factor VIII on its immunogenicity in hemophilia a mice. J Pharm Sci 98:4480\u20134484. https:\/\/doi.org\/10.1002\/jps.21765","journal-title":"J Pharm Sci"},{"key":"685_CR34","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00216-019-01633-4","volume":"411","author":"J-P Salvador","year":"2019","unstructured":"Salvador J-P, Vilaplana L, Marco M-P (2019) Nanobody: outstanding features for diagnostic and therapeutic applications. Anal Bioanal Chem 411:1703\u20131713. https:\/\/doi.org\/10.1007\/s00216-019-01633-4","journal-title":"Anal Bioanal Chem"},{"key":"685_CR35","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/bjd.17852","volume":"181","author":"H Shi","year":"2019","unstructured":"Shi H, Zhou H, Ma A et al (2019) Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis. Br J Dermatol 181:1028\u20131037. https:\/\/doi.org\/10.1111\/bjd.17852","journal-title":"Br J Dermatol"},{"key":"685_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1177\/1535370214525315","volume":"239","author":"H Song","year":"2014","unstructured":"Song H, Pan B, Yi J et al (2014) Featured article: autophagic activation with Nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma. Exp Biol Med 239:529\u2013541. https:\/\/doi.org\/10.1177\/1535370214525315","journal-title":"Exp Biol Med"},{"key":"685_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.intimp.2016.10.019","volume":"41","author":"X Sun","year":"2016","unstructured":"Sun X, Zhang C, Jin H et al (2016) Flow cytometric analysis of T lymphocyte proliferation in vivo by EdU incorporation. Int Immunopharmacol 41:56\u201365. https:\/\/doi.org\/10.1016\/j.intimp.2016.10.019","journal-title":"Int Immunopharmacol"},{"key":"685_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jaad.2019.03.056","volume":"81","author":"D Svecova","year":"2019","unstructured":"Svecova D, Lubell MW, Casset-Semanaz F et al (2019) A randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin 17A\/F nanobody, in moderate-to-severe psoriasis. J Am Acad Dermatol 81:196\u2013203. https:\/\/doi.org\/10.1016\/j.jaad.2019.03.056","journal-title":"J Am Acad Dermatol"},{"key":"685_CR39","doi-asserted-by":"publisher","first-page":"175276","DOI":"10.1016\/j.ejphar.2022.175276","volume":"933","author":"J Tang","year":"2022","unstructured":"Tang J, Liu C, Liu S et al (2022a) Inhibition of JAK1\/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model. Eur J Pharmacol 933:175276. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175276","journal-title":"Eur J Pharmacol"},{"key":"685_CR40","first-page":"48","volume":"77","author":"J Tang","year":"2022","unstructured":"Tang J, Zhou Z, Qian J et al (2022b) KdPT alleviates imiquimod-induced psoriasis-like skin lesion in mice via inhibiting proliferation and inflammation response. Pharmazie 77:48\u201353","journal-title":"Pharmazie"},{"key":"685_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.clinthera.2010.03.012","volume":"32","author":"J Tol","year":"2010","unstructured":"Tol J, Punt CJA (2010) Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. Clin Ther 32:437\u2013453. https:\/\/doi.org\/10.1016\/j.clinthera.2010.03.012","journal-title":"Clin Ther"},{"key":"685_CR42","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4049\/jimmunol.1102224","volume":"188","author":"AB Van Belle","year":"2012","unstructured":"Van Belle AB, de Heusch M, Lemaire MM et al (2012) IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol 188:462\u2013469. https:\/\/doi.org\/10.4049\/jimmunol.1102224","journal-title":"J Immunol"},{"key":"685_CR43","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits L, Mourits S, Voerman JSA et al (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182:5836\u20135845. https:\/\/doi.org\/10.4049\/jimmunol.0802999","journal-title":"J Immunol"},{"key":"685_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/CCO.0b013e32833edbdf","volume":"22","author":"I Vivanco","year":"2010","unstructured":"Vivanco I, Mellinghoff IK (2010) Epidermal growth factor receptor inhibitors in oncology. Curr Opin Oncol 22:573\u2013578. https:\/\/doi.org\/10.1097\/CCO.0b013e32833edbdf","journal-title":"Curr Opin Oncol"},{"key":"685_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/prep.2000.1310","volume":"20","author":"P Wang","year":"2000","unstructured":"Wang P, Zhang J, Sun Z et al (2000) Glycosylation of prourokinase produced by Pichia pastoris impairs enzymatic activity but not secretion. Protein Expr Purif 20:179\u2013185. https:\/\/doi.org\/10.1006\/prep.2000.1310","journal-title":"Protein Expr Purif"},{"key":"685_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/1574892815666200904111728","volume":"15","author":"L Wang","year":"2020","unstructured":"Wang L, Zhang G, Qin L et al (2020) Anti-EGFR binding nanobody delivery system to improve the diagnosis and treatment of solid tumours. Recent Pat Anticancer Drug Discov 15:200\u2013211. https:\/\/doi.org\/10.2174\/1574892815666200904111728","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"685_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0962-8924(01)01955-9","volume":"11","author":"S Werner","year":"2001","unstructured":"Werner S, Smola H (2001) Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol 11:143\u2013146. https:\/\/doi.org\/10.1016\/S0962-8924(01)01955-9","journal-title":"Trends Cell Biol"},{"key":"685_CR48","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.18632\/oncotarget.1312","volume":"4","author":"X Wu","year":"2013","unstructured":"Wu X, Huang H, Wang C et al (2013) Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation. Oncotarget 4:1819\u20131828. https:\/\/doi.org\/10.18632\/oncotarget.1312","journal-title":"Oncotarget"},{"key":"685_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.molimm.2020.04.002","volume":"122","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Wang C, Zeng B et al (2020) miR124-3p\/FGFR2 axis inhibits human keratinocyte proliferation and migration and improve the inflammatory microenvironment in psoriasis. Mol Immunol 122:89\u201398. https:\/\/doi.org\/10.1016\/j.molimm.2020.04.002","journal-title":"Mol Immunol"},{"key":"685_CR50","unstructured":"Xiong S, Xie Q, Chen C et al (2022) Application of anti-recombinant human basic fibroblast growth factor nanobody. CN Patent CN113150141 B"},{"key":"685_CR51","doi-asserted-by":"publisher","first-page":"719842","DOI":"10.3389\/fphar.2021.719842","volume":"12","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhu J, Hu J et al (2021) L-theanine alleviates IMQ-induced psoriasis like skin inflammation by downregulating the production of IL-23 and chemokines. Front Pharmacol 12:719842. https:\/\/doi.org\/10.3389\/fphar.2021.719842","journal-title":"Front Pharmacol"},{"key":"685_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2340\/00015555738183","volume":"73","author":"H Yaguchi","year":"1993","unstructured":"Yaguchi H, Tsuboi R, Ueki R et al (1993) Immunohistochemical localization of basic fibroblast growth factor in skin diseases. Acta Derm Venereol 73:81\u201383","journal-title":"Acta Derm Venereol"},{"key":"685_CR53","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3389\/fonc.2020.01182","volume":"10","author":"EY Yang","year":"2020","unstructured":"Yang EY, Shah K (2020) Nanobodies: next generation of cancer diagnostics and therapeutics. Front Oncol 10:1182. https:\/\/doi.org\/10.3389\/fonc.2020.01182","journal-title":"Front Oncol"},{"key":"685_CR54","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/toxins12040273","volume":"12","author":"C Zhang","year":"2020","unstructured":"Zhang C, Zhang W, Tang X et al (2020) Change of amino acid residues in idiotypic nanobodies enhanced the sensitivity of competitive enzyme immunoassay for mycotoxin ochratoxin A in Cereals. Toxins 12:273. https:\/\/doi.org\/10.3390\/toxins12040273","journal-title":"Toxins"},{"key":"685_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen Y, Cui L et al (2022) Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis 13:81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3","journal-title":"Cell Death Dis"},{"key":"685_CR56","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2353\/ajpath.2006.050479","volume":"168","author":"SI Zittermann","year":"2006","unstructured":"Zittermann SI, Issekutz AC (2006) Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol 168:835\u2013846. https:\/\/doi.org\/10.2353\/ajpath.2006.050479","journal-title":"Am J Pathol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-023-00685-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-023-00685-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-023-00685-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:50:04Z","timestamp":1704228604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-023-00685-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1007\/s00005-023-00685-w","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All animal experiments were approved by the Animal Ethical Committees of Jinan University, Guangzhou, China.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"20"}}